Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.365 USD | +1.11% | -4.83% | -25.00% |
05-21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.00% | 196M | |
-24.16% | 7.66B | |
+67.85% | 4.35B | |
+2.72% | 2.62B | |
-2.98% | 2.53B | |
-46.17% | 2.21B | |
-15.20% | 1.79B | |
-22.73% | 1.48B | |
+13.62% | 1.18B | |
-43.81% | 1.13B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target